Riccio, G.; Berenguer, C.V.; Perestrelo, R.; Pereira, F.; Berenguer, P.; Ornelas, C.P.; Sousa, A.C.; Vital, J.A.; Pinto, M.d.C.; Pereira, J.A.M.;
et al. Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers. Curr. Oncol. 2023, 30, 4904-4921.
https://doi.org/10.3390/curroncol30050370
AMA Style
Riccio G, Berenguer CV, Perestrelo R, Pereira F, Berenguer P, Ornelas CP, Sousa AC, Vital JA, Pinto MdC, Pereira JAM,
et al. Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers. Current Oncology. 2023; 30(5):4904-4921.
https://doi.org/10.3390/curroncol30050370
Chicago/Turabian Style
Riccio, Giulia, Cristina V. Berenguer, Rosa Perestrelo, Ferdinando Pereira, Pedro Berenguer, Cristina P. Ornelas, Ana Célia Sousa, João Aragão Vital, Maria do Carmo Pinto, Jorge A. M. Pereira,
and et al. 2023. "Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers" Current Oncology 30, no. 5: 4904-4921.
https://doi.org/10.3390/curroncol30050370
APA Style
Riccio, G., Berenguer, C. V., Perestrelo, R., Pereira, F., Berenguer, P., Ornelas, C. P., Sousa, A. C., Vital, J. A., Pinto, M. d. C., Pereira, J. A. M., Greco, V., & Câmara, J. S.
(2023). Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers. Current Oncology, 30(5), 4904-4921.
https://doi.org/10.3390/curroncol30050370
